rosiglitazone has been researched along with Cachexia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Geldenhuys, W; Pistilli, EE; Rellick, S; Stanton, DA; Wilson, HE | 1 |
| Chen, SZ; Xiao, JD | 1 |
| Chevalier, S; Farsijani, S | 1 |
| Anker, SD; Doehner, W; Lainscak, M; Palus, S; Springer, J; Trobec, K; Tschirner, A; von Haehling, S | 1 |
| Asp, ML; Belury, MA; Tian, M; Wendel, AA | 1 |
| Asp, ML; Belury, MA; Kliewer, KL; Tian, M | 1 |
1 review(s) available for rosiglitazone and Cachexia
| Article | Year |
|---|---|
Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment.
Topics: Adipose Tissue; Animals; Cachexia; Diabetes Mellitus, Type 2; Energy Metabolism; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Muscular Atrophy; Neoplasms; Nutritional Support; Proteins; Rosiglitazone; Thiazolidinediones | 2014 |
5 other study(ies) available for rosiglitazone and Cachexia
| Article | Year |
|---|---|
Breast cancer-associated skeletal muscle mitochondrial dysfunction and lipid accumulation is reversed by PPARG.
Topics: Animals; Breast Neoplasms; Cachexia; Cell Line, Tumor; Culture Media, Conditioned; Female; HEK293 Cells; Humans; Lipid Metabolism; Mice; Mitochondria, Muscle; Myoblasts, Skeletal; Paracrine Communication; PPAR gamma; Rosiglitazone; Signal Transduction; Transcription, Genetic | 2021 |
Rosiglitazone and imidapril alone or in combination alleviate muscle and adipose depletion in a murine cancer cachexia model.
Topics: Adipose Tissue; Animals; Biomarkers; Body Weight; Cachexia; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Gene Expression Regulation; Imidazolidines; Inflammation Mediators; Insulin; Male; Mice; Muscle Proteins; Muscles; Muscular Atrophy; Neoplasms; Organ Size; Rosiglitazone; SKP Cullin F-Box Protein Ligases; Thiazolidinediones; Tripartite Motif Proteins; Tumor Burden; Ubiquitin-Protein Ligases | 2014 |
Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
Topics: Adipose Tissue; Animals; Body Composition; Body Fluid Compartments; Cachexia; Cardiac Output; Disease Models, Animal; Heart; Hypoglycemic Agents; Male; Muscle, Skeletal; Neoplasms; Random Allocation; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Ventricular Function, Left; Weight Loss | 2014 |
Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice.
Topics: Adenocarcinoma; Adiponectin; Animals; Autophagy; Blood Glucose; Cachexia; Colonic Neoplasms; Crosses, Genetic; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Muscle, Skeletal; Muscular Atrophy; Neoplasm Proteins; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-akt; Random Allocation; Rosiglitazone; Thiazolidinediones; Weight Loss | 2010 |
Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia.
Topics: Adipose Tissue; Animals; Anorexia; Blood Glucose; Cachexia; Eating; Humans; Hypoglycemic Agents; Inflammation; Insulin Resistance; Mice; Muscle Strength; Neoplasms; Organ Size; Proteolysis; Rosiglitazone; Thiazolidinediones; Weight Loss | 2011 |